Article Details

Catalyst Pharmaceuticals' (NASDAQ:CPRX) “Buy” Rating Reiterated at Cantor Fitzgerald

Retrieved on: 2019-04-10 13:03:45

Tags for this article:

Click the tags to see associated articles and topics

Catalyst Pharmaceuticals' (NASDAQ:CPRX) “Buy” Rating Reiterated at Cantor Fitzgerald. View article details on hiswai:

Excerpt

<div>Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. <b>Sofinnova Ventures</b> Inc lifted its position ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up